Cargando…

Alterations in Immune-Related Genes as Potential Marker of Prognosis in Breast Cancer

The tumor microenvironment (TME) is a heterogeneous system that contributes to breast cancer progression. The Cancer Genome Atlas (TCGA) database provides global gene expression profiling data for further analysis of various malignancies, including breast cancer. Based on the ESTIMATE algorithm, imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bei, Geng, Rongxin, Wu, Qi, Yang, Qian, Sun, Si, Zhu, Shan, Xu, Zhiliang, Sun, Shengrong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080956/ https://www.ncbi.nlm.nih.gov/pubmed/32226776 http://dx.doi.org/10.3389/fonc.2020.00333

Ejemplares similares

Expression of Monocarboxylate Transporter 1 in Immunosuppressive Macrophages Is Associated With the Poor Prognosis in Breast Cancer
por: Li, Bei, et al.
Publicado: (2020)

Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas
por: Xu, Yang, et al.
Publicado: (2021)

GMFG Has Potential to Be a Novel Prognostic Marker and Related to Immune Infiltrates in Breast Cancer
por: Yang, Yan, et al.
Publicado: (2021)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
por: Nie, Yuan, et al.
Publicado: (2021)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

A novel pyroptosis-related indicator of immune infiltration features and prognosis in breast cancer
por: Wang, Cheng, et al.
Publicado: (2022)

FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration
por: Cai, Jiayang, et al.
Publicado: (2022)

Predicting the immune microenvironment and prognosis with a anoikis - related signature in breast cancer
por: Lu, Xiuqing, et al.
Publicado: (2023)

NRBP2 Functions as a Tumor Suppressor and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer
por: Li, Zhiyu, et al.
Publicado: (2021)

An Immune-Related Gene Pairs Signature Predicts Prognosis and Immune Heterogeneity in Glioblastoma
por: Zhang, Nijia, et al.
Publicado: (2021)

Identification of UCP1 and UCP2 as Potential Prognostic Markers in Breast Cancer: A Study Based on Immunohistochemical Analysis and Bioinformatics
por: Yu, Xin, et al.
Publicado: (2022)

Centrosome dysfunction: a link between senescence and tumor immunity
por: Wu, Qi, et al.
Publicado: (2020)

Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?
por: Whiteside, Theresa L.
Publicado: (2013)

Identification of an Aging-Related Gene Signature in Predicting Prognosis and Indicating Tumor Immune Microenvironment in Breast Cancer
por: Lv, Wenchang, et al.
Publicado: (2021)

VISTA Expression on Immune Cells Correlates With Favorable Prognosis in Patients With Triple-Negative Breast Cancer
por: Cao, Xi, et al.
Publicado: (2021)

Exploration the Significance of a Novel Immune-Related Gene Signature in Prognosis and Immune Microenvironment of Breast Cancer
por: Zhao, Yajie, et al.
Publicado: (2020)

Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis
por: Li, Ying, et al.
Publicado: (2021)

Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma
por: Qin, Zhongqiang, et al.
Publicado: (2023)

Cancer-associated adipocytes: key players in breast cancer progression
por: Wu, Qi, et al.
Publicado: (2019)

An Immunity-Related Gene Model Predicts Prognosis in Cholangiocarcinoma
por: Guo, Han, et al.
Publicado: (2022)

Radiogenomics analysis reveals the associations of dynamic contrast-enhanced–MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer
por: Ming, Wenlong, et al.
Publicado: (2022)

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis
por: Sun, Qian, et al.
Publicado: (2022)

Identification of PAFAH1B3 as Candidate Prognosis Marker and Potential Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Weikang, et al.
Publicado: (2021)

Integrative dissection of 5-hydroxytryptamine receptors-related signature in the prognosis and immune microenvironment of breast cancer
por: Zhan, Dandan, et al.
Publicado: (2023)

Breast cancer-released exosomes trigger cancer-associated cachexia to promote tumor progression
por: Wu, Qi, et al.
Publicado: (2018)

Rap GTPase Interactor: A Potential Marker for Cancer Prognosis Following Kidney Transplantation
por: Fu, Qiang, et al.
Publicado: (2019)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
por: Na, Lei, et al.
Publicado: (2020)

Identification of a tumor immune-inflammation signature predicting prognosis and immune status in breast cancer
por: Liu, Yajing, et al.
Publicado: (2023)

An Immune Model to Predict Prognosis of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy Based on Support Vector Machine
por: Wang, Mozhi, et al.
Publicado: (2021)

Necroptosis-Related LncRNAs Signature and Subtypes for Predicting Prognosis and Revealing the Immune Microenvironment in Breast Cancer
por: Xu, Yuhao, et al.
Publicado: (2022)

Breast carcinoma in situ: An observational study of tumor subtype, treatment and outcomes
por: Wu, Qi, et al.
Publicado: (2016)

MiR-873-5p: A Potential Molecular Marker for Cancer Diagnosis and Prognosis
por: Zou, Yuhao, et al.
Publicado: (2021)

Identification of Potential Key Genes Associated With the Pathogenesis, Metastasis, and Prognosis of Triple-Negative Breast Cancer on the Basis of Integrated Bioinformatics Analysis
por: Zhao, Bin, et al.
Publicado: (2020)

Prevalence of Phosphatidylinositol-3-Kinase (PI3K) Pathway Alterations and Co-alteration of Other Molecular Markers in Breast Cancer
por: Khoury, Katia, et al.
Publicado: (2020)

A Prognosis Marker SLC2A3 Correlates With EMT and Immune Signature in Colorectal Cancer
por: Gao, Huabin, et al.
Publicado: (2021)

Clinicopathologic features, treatment, and prognosis of pregnancy-associated breast cancer
por: Li, Yuechong, et al.
Publicado: (2022)

Effect of activating cancer-associated fibroblasts biomarker TNC on immune cell infiltration and prognosis in breast cancer
por: Huang, Ting, et al.
Publicado: (2023)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
por: Su, Yuanshuai, et al.
Publicado: (2023)

A cuproptosis-related genes signature associated with prognosis and immune cell infiltration in osteosarcoma
por: Yang, Weiguang, et al.
Publicado: (2022)

Research progress and value of albumin-related inflammatory markers in the prognosis of non-small cell lung cancer: a review of clinical evidence
por: Zhang, Chuan-long, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m5f2nfbgviiafpkj4j1roqgtmt